References
Voeten DM, den Bakker CM, Heineman DJ et al (2019) Definitive chemoradiotherapy versus trimodality therapy for resectable oesophageal carcinoma: meta-analyses and systematic review of literature. World J Surg. https://doi.org/10.1007/s00268-018-04901-z
Deng HY, Li G, Luo J et al (2018) Can definitive chemoradiotherapy be an alternative to surgery for early-stage oesophageal cancer? Interact Cardiovasc Thorac Surg 28:37–40
Wang BY, Hung WH, Wu SC et al (2018) Comparison between esophagectomy and definitive chemoradiotherapy in patients with esophageal cancer. Ann Thorac Surg. https://doi.org/10.1016/j.athoracsur.2018.11.036
NCCN Guidelines for Treatment of Cancer by Site: Esophageal and Esophagogastric Junction Cancers. https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf. Accessed 5 Jan 2018
Ma MW, Gao XS, Gu XB et al (2018) The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma World journal of surgical oncology 16:172
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Deng, HY. Letter to the Editor: Definitive Chemoradiotherapy Versus Trimodality Therapy for Resectable Oesophageal Carcinoma: Meta-analyses and Systematic Review of Literature. World J Surg 43, 1869–1870 (2019). https://doi.org/10.1007/s00268-019-04933-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-019-04933-z